AU2003226628A1 - METHYL-Beta-ORCINOLCARBOXYLATE FROM LICHEN (EVERNIASTRUM CIRRHATUM) FOR USE FOR THE TREATMENT OF FUNGAL INFECTIONS AND CANCER - Google Patents

METHYL-Beta-ORCINOLCARBOXYLATE FROM LICHEN (EVERNIASTRUM CIRRHATUM) FOR USE FOR THE TREATMENT OF FUNGAL INFECTIONS AND CANCER

Info

Publication number: AU2003226628A1
Authority: AU; Australia
Prior art keywords: orcinolcarboxylate; lichen; beta; cancer; methyl
Prior art date: 2003-03-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003226628A

Inventor

Preeti Chand

Mahendra Pandurang Darokar

Ankur Garg

Vivek Kumar Gupta

Suman Preet Singh Khanuja

Anirban Pal

Dharmendra Saikia

Ajit Kumar Shasany

Santosh Kumar Srivastava

Ranganathan Santha Kumar Tiruppadiripuliyur

Subash Chandra Verma

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Council of Scientific and Industrial Research CSIR

Original Assignee

Council of Scientific and Industrial Research CSIR

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-31

Filing date

2003-03-31

Publication date

2004-10-25

2003-03-31 Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR

2004-10-25 Publication of AU2003226628A1 publication Critical patent/AU2003226628A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/09—Lichens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Natural Medicines & Medicinal Plants (AREA)
Microbiology (AREA)
Mycology (AREA)
Alternative & Traditional Medicine (AREA)
Communicable Diseases (AREA)
Endocrinology (AREA)
Oncology (AREA)
Reproductive Health (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2003226628A 2003-03-31 2003-03-31 METHYL-Beta-ORCINOLCARBOXYLATE FROM LICHEN (EVERNIASTRUM CIRRHATUM) FOR USE FOR THE TREATMENT OF FUNGAL INFECTIONS AND CANCER Abandoned AU2003226628A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IN2003/000097 WO2004087128A1 (en)	2003-03-31	2003-03-31	Methyl-β-orcinolcarboxylate from lichen (everniastrum cirrhatum) for use for the treatment of fungal infections and cancer

Publications (1)

Publication Number	Publication Date
AU2003226628A1 true AU2003226628A1 (en)	2004-10-25

Family

ID=33104946

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003226628A Abandoned AU2003226628A1 (en)	2003-03-31	2003-03-31	METHYL-Beta-ORCINOLCARBOXYLATE FROM LICHEN (EVERNIASTRUM CIRRHATUM) FOR USE FOR THE TREATMENT OF FUNGAL INFECTIONS AND CANCER

Country Status (6)

Country	Link
JP (1)	JP4498930B2 (en)
AU (1)	AU2003226628A1 (en)
CA (1)	CA2521055A1 (en)
DE (1)	DE10394214T5 (en)
GB (1)	GB2415379B (en)
WO (1)	WO2004087128A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006137172A1 (en) *	2005-06-24	2006-12-28	Taiyo Kagaku Co., Ltd.	Pest control agent of fungi or parasites for fish
JP2010202562A (en) *	2009-03-03	2010-09-16	Ogawa & Co Ltd	Phenol-based antimicrobial agent
US20240091289A1 (en) *	2020-07-27	2024-03-21	Zoo Pharma Dynamics, Llc	Lichen Extract-based Formulation for Cervids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3560290B2 (en) *	1991-11-27	2004-09-02	大日本除蟲菊株式会社	Antimicrobial agent against methicillin-resistant Staphylococcus aureus

2003
- 2003-03-31 JP JP2004570066A patent/JP4498930B2/en not_active Expired - Fee Related
- 2003-03-31 WO PCT/IN2003/000097 patent/WO2004087128A1/en not_active Ceased
- 2003-03-31 AU AU2003226628A patent/AU2003226628A1/en not_active Abandoned
- 2003-03-31 DE DE10394214T patent/DE10394214T5/en not_active Withdrawn
- 2003-03-31 GB GB0522200A patent/GB2415379B/en not_active Expired - Fee Related
- 2003-03-31 CA CA002521055A patent/CA2521055A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004087128A1 (en)	2004-10-14
GB2415379B (en)	2007-10-31
DE10394214T5 (en)	2006-03-16
JP2006514969A (en)	2006-05-18
CA2521055A1 (en)	2004-10-14
GB0522200D0 (en)	2005-12-07
JP4498930B2 (en)	2010-07-07
GB2415379A (en)	2005-12-28

Similar Documents

Publication	Publication Date	Title
EP2671581B8 (en)	2019-11-13	Compositions and methods for treating cancer
AU2003254038A1 (en)	2004-02-16	Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
AU2003230750A1 (en)	2003-10-13	Compositions and methods for treating cancer
AU2003213144A1 (en)	2003-09-09	Alkylating agent combinations in the treatment of cancer
AU2003255482A1 (en)	2004-04-23	Use of 4 amino-quinazolines as anti cancer agents
AU2003212634A1 (en)	2003-09-22	Compounds useful in the treatment of cancer
AU2003225535A1 (en)	2003-09-02	Methods and compositions for treating cancer
AU2003258662A1 (en)	2004-04-23	Use of 4-amino-quinazolines as anti cancer agents
AU2003219160A1 (en)	2004-09-30	Methods and compositions for the treatment of cancer
AU2003285281A1 (en)	2004-06-18	Topical application of curcumin for the treatment of peripheral neuropathy
AU2003223538A1 (en)	2003-10-27	Methods for the treatment of cancer
AU2003296963A1 (en)	2004-07-09	Methods and compositions for treating and preventing ear infections
AU2003291886A1 (en)	2004-06-30	Thiophenederivatives for the treatment of flavivirus infections
AU2003274963A1 (en)	2004-07-29	Mda-7 and free radicals in the treatment of cancer
AU2003258983A1 (en)	2004-01-19	Combinations for the treatment of fungal infections
AU2003220026A1 (en)	2003-09-16	Methods and compositions for the treatment of ischemia
AU2002337713A1 (en)	2003-04-07	Pharmaceutical compositions and methods for treating cancer
AU2003226628A1 (en)	2004-10-25	METHYL-Beta-ORCINOLCARBOXYLATE FROM LICHEN (EVERNIASTRUM CIRRHATUM) FOR USE FOR THE TREATMENT OF FUNGAL INFECTIONS AND CANCER
AU2002366195A1 (en)	2003-06-10	Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2003296242A1 (en)	2004-06-18	Thia-epothilone derivatives for the treatment of cancer
AU2004281077A1 (en)	2005-04-28	Methods and agents for the treatment of cancer
AU2003231803A1 (en)	2003-12-02	Treatment of cancer with mefloquire
AU2002310922A1 (en)	2002-11-18	Interferons in the treatment of ischemia
AU2003212888A1 (en)	2003-09-02	Combinations for the treatment of fungal infections
GB0701454D0 (en)	2007-03-07	Methyl-B-oreinolcarboxylate from lichen (Everniastrum cirrhatum) for use for the treatment of fungal infections

Legal Events

Date	Code	Title	Description
2005-12-15	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase